Lenz & Staehelin advised Kartesia, an European provider of financing solutions for small and mid-sized companies, which has provided a flexible secured debt financing package to support Symbios Orthopédie in its growth strategy. Lenz &
WalderWyss advised Klar on Bühlmann’s all shares acquisition. Vischer provided legal and tax advice to Dr. Roland P. Bühlmann and Marie-Thérèse Bühlmann in this transaction. Located in Schönenbuch (
Homburger advised Apellis Pharmaceuticals on its senior secured USD 475 million financing on all swiss legal aspects of the transaction. Homburger’s team Daniel Haeberli (pictured) led Homburger’s team which further included Laura Müller,
WalderWyss advised Migros-Genossenschafts-Bund (MGB) on the sale of its susbsidiary Misenso to the Neuroth group. As the new owner, the Neuroth Group will continue to operate Misenso under its current name and at its current
Kellerhals Carrard advised Natural Cycles on its $55 mln financing round led by Lauxera Capital Partners and which saw participation from Point72 Private Investments and a revolving debt facility from J.P. Morgan. Kellerhals Carrard’s
Kontivia Beteiligungen, a Zurich based long term oriented investment firm advised by Kellerhals Carrard, led a group of swiss entrepreneurial families, advised by Baker McKenzie, in the acquisition of a majority stake in Walter Meier (
Boris Zaïtra (pictured), currently head of group business development, will be appointed as head of corporate business development, effective 1 july 2024. James Sabry, head of Roche Pharma Partnering, will be retiring after fourteen years in
Walder Wyss advised SixPeaks Bio in securing USD 30 million in Series A financing led by founding investor Versant Ventures and a strategic collaboration with AstraZeneca. The latter, advised by Lenz & Staehelin, will provide additional,
Homburger advised Sonova as a borrower in a CHF 400 million term and revolving credit facility agreement governed by Swiss law. UBS Switzerland acted as the mandated lead arranger and agent for an international bank syndacate.
Walder Wyss advised the funds managed by Perceptive Advisor, a privately owned hedge fund sponsor investing in biotechnology and life sciences sectors, on the secured term loan financing for up USD 50,000,000 granted to Sophia Genetics,
